Search results for "Portal hypertension"

showing 10 items of 85 documents

Enteroscopic Cyanoacrylate Sclerotherapy of Jejunal and Gallbladder Varices in a Patient with Portal Hypertension

2001

Bleeding from varices outside the gastroesophageal region is a rare, but regularly reported complication of portal hypertension. The treatment differs from the management of esophageal and gastric varices. We present here a report on the diagnosis and treatment of bleeding jejunal and gallbladder varices in a man with portal hypertension caused by chronic calcifying pancreatitis. The patient was suffering from recurrent, frequent, and massive gastrointestinal bleeding from varices at the anastomotic area of a cholecystojejunostomy. For diagnostic purposes, we carried out percutaneous Duplex ultrasonography and push enteroscopy with the Doppler technique. The treatment of varices in this are…

Malemedicine.medical_specialtyGastrointestinal bleedingmedicine.medical_treatmentHemorrhageGallbladder DiseasesAnastomosisVaricose VeinsHypertension PortalSclerotherapymedicineSclerotherapyHumansCyanoacrylatesEndoscopy Digestive SystemUltrasonography Doppler DuplexVarixbusiness.industryGallbladderGastroenterologyGallbladderJejunal DiseasesMiddle AgedGastric varicesmedicine.diseaseSurgeryJejunummedicine.anatomical_structurePortal hypertensionRadiologyVaricesbusinessEndoscopy
researchProduct

HCV cirrhosis at the edge of decompensation: Will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?

2014

BACKGROUND: The interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r) and the NS5A inhibitor ombitasvir (also known as ABT-267) plus the nonnucleoside polymerase inhibitor dasabuvir (also known as ABT-333) and ribavirin has shown efficacy against the hepatitis C virus (HCV) in patients with HCV genotype 1 infection. In this phase 3 trial, we evaluated this regimen in previously untreated patients with HCV genotype 1 infection and no cirrhosis. METHODS: In this multicenter, randomized, double-blind, placebocontrolled trial, we assigned previously untreated patients with HCV genotype 1 infection, in a 3:1 ratio, to an active regimen consisting of a single-ta…

Malemedicine.medical_specialtyMacrocyclic CompoundsDirect-acting antiviralsLiver functionGastroenterologyAntiviral Agents03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePegylated interferonInternal medicineRibavirinmedicineHumansAnilidesPortal hypertensionUracilAdvanced liver diseaseSulfonamidesDasabuvirRitonavirHepatologybusiness.industryRibavirinvirus diseasesHepatitis C ChronicVirologyOmbitasvir3. Good healthRegimenchemistryParitaprevir030220 oncology & carcinogenesis030211 gastroenterology & hepatologyRitonavirFemaleLiver functionCarbamatesbusinessmedicine.drugJournal of Hepatology
researchProduct

NEONATAL CAPSAICIN TREATMENT DOES NOT PREVENT SPLANCHNIC VASODILATATION IN PORTAL-HYPERTENSIVE RATS

1994

It has been suggested that the peripheral sensory neurons are involved in the splanchnic hemodynamic changes of portal hypertension. Therefore the influence of permanent ablation of sensory neurons by neonatal capsaicin pretreatment (50 mg/kg, subcutaneously) on the development of the hyperdynamic splanchnic circulation in portal-hypertensive rats was studied. In adulthood, portal hypertension was induced with partial portal vein ligation. In study 1, systemic and splanchnic hemodynamics were measured by means of a radiolabeled-microsphere technique in portal-hypertensive rats, under ketamine anesthesia, pretreated with capsaicin or vehicle. Mean arterial pressure, heart rate, cardiac index…

Malemedicine.medical_specialtyMean arterial pressureCalcitonin Gene-Related PeptidePortal venous pressureHemodynamicschemistry.chemical_compoundInternal medicineHypertension PortalmedicineAnimalsNeurons AfferentSplanchnic CirculationRats WistarHepatologySplanchnic Circulationbusiness.industryHemodynamicsmedicine.diseaseRatsmedicine.anatomical_structureEndocrinologyAnimals NewbornchemistryGastric MucosaRegional Blood FlowCapsaicinVascular resistancePortal hypertensionCapsaicinSplanchnicbusinessDigestive SystemDilatation Pathologic
researchProduct

Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension

1986

Summary Hydroxyethyl starch (HES) has gained wide clinical acceptance as a colloidal plasma substitute. We were able to study the liver biopsies of two patients with renal failure who developed ascites after repeated infusions of HES. All types of liver cells displayed massive accumulation of HES with the morphologic resemblance to a storage disease. These changes could be distinguished clearly from the lesions of a hereditary disorder by light and electron microscopy. Although it is difficult to establish a causative role for HES in the development of ascites on the bases of morphological changes alone, one should be cautious about giving HES to patients with renal failure until exact data…

Malemedicine.medical_specialtyResuscitationPathologyHydroxyethyl starchHydroxyethyl Starch DerivativesRenal DialysisHypertension PortalAscitesmedicineHumansreproductive and urinary physiologyHepatologybusiness.industryStarchMiddle Agedmedicine.diseaseSurgeryMicroscopy ElectronLiverKidney Failure ChronicPortal hypertensionFemaleHypotensionbiological phenomena cell phenomena and immunitymedicine.symptombusinessPerfusionmedicine.drugJournal of Hepatology
researchProduct

Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats

1996

The present study evaluates the effects of pre-hepatic portal hypertension, induced in rats by partial portal vein ligation, on the responsiveness of rostral (proximal) and caudal (distal) rings from the mesenteric vein. The anatomical origin of the sample influenced the response to vasoconstrictors in sham-operated animals, and this pattern of reactivity was specifically modified in portal-ligated rats. In veins from sham-operated rats, contraction induced by a submaximal concentration of KCl (60 mM) was greater in proximal than in distal rings. Vasopressin and 5-hydroxytryptamine contracted mainly distal rings, methoxamine showed a greater effect on proximal rings, and endothelin-1 and an…

Malemedicine.medical_specialtyVasopressinContraction (grammar)VasopressinsPropranololIliac VeinIn Vitro TechniquesMuscle Smooth VascularMesenteric VeinMethoxaminePotassium ChlorideNitric oxideRats Sprague-Dawleychemistry.chemical_compoundMesenteric VeinsInternal medicineHypertension PortalmedicineAnimalsVasoconstrictor AgentsPharmacologyEndothelin-1business.industryGeneral Medicinemedicine.diseaseRatsAtropineEndocrinologychemistrycardiovascular systemPortal hypertensionbusinessmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Fibropolycystic Liver Disease: CT and MR Imaging Findings

2005

Fibropolycystic liver disease encompasses a spectrum of related lesions of the liver and biliary tract that are caused by abnormal embryologic development of the ductal plates. These lesions (congenital hepatic fibrosis, biliary hamartomas, autosomal dominant polycystic disease, Caroli disease, choledochal cysts) can be clinically silent or can cause signs and symptoms such as cholangitis, portal hypertension, gastrointestinal bleeding, infections, and space-occupying masses. The different types of fibropolycystic liver disease demonstrate characteristic findings at computed tomography (CT) and magnetic resonance (MR) imaging. Patients with congenital hepatic fibrosis typically have imaging…

Pathologymedicine.medical_specialtyCaroli diseaseBile Duct DiseasesLiver diseasemedicineHumansRadiology Nuclear Medicine and imagingCholedochal cystsmedicine.diagnostic_testCystsBile ductbusiness.industryLiver DiseasesMagnetic resonance imagingmedicine.diseaseFibrosisMagnetic Resonance ImagingCaroli Diseasemedicine.anatomical_structureLiverBiliary tractCongenital hepatic fibrosisPortal hypertensionBile DuctsRadiologyTomography X-Ray ComputedbusinessCholangiographyRadioGraphics
researchProduct

Die Milz bei Lebererkrankungen

1970

In patients with diseases of the liver portal hypertension and cellular proliferation produce reactive changes in the spleen. The size of the spleen and its function as a filter were determined quantitatively with isotope-labeled, heat-induced spherocytes. In 96% of the investigated liver diseases (acute and chronic hepatitis, cirrhosis and steatosis of the liver) either the size or the filter function of the organ are altered, frequently both of them.

Pathologymedicine.medical_specialtyCirrhosisbusiness.industryFilter (function)Spleenmedicine.diseasemedicine.anatomical_structureChronic hepatitismedicinePortal hypertensionIn patientSteatosisbusiness
researchProduct

Fibrospleen: Measuring spleen stiffness by transient elastography increases accuracy of staging of liver fibrosis and of portal hypertension in chron…

2009

Pathologymedicine.medical_specialtyHepatologybusiness.industryLiver fibrosisGastroenterologySpleenmedicine.diseasemedicine.anatomical_structuremedicinePortal hypertensionViral hepatitisTransient elastographybusinessDigestive and Liver Disease
researchProduct

Pancreatitis autoinmune: pseudotumor inflamatorio, afectación multifocal, hipertensión portal y evolución a largo plazo

2008

Autoimmune pancreatitis is a recently characterized disease that still constitutes a diagnostic challenge, especially regarding differential diagnosis from neoplasia. Long-term outcome is poorly known. We herein report a case of a patient with autoimmune pancreatitis and 14 years of follow-up, and show its clinical, biochemical, and morphological characteristics. A 54-year-old female presented with obstructive jaundice and abdominal tenderness, as well as a mass at the pancreatic head on a CT scan, suggestive of pancreatic neoplasia. Surgery showed an increase of the whole pancreas, malignancy was intraoperatively ruled out, and a cholecystectomy and choledochoduodenostomy were carried out.…

Pathologymedicine.medical_specialtybusiness.industryGastroenterologyGeneral MedicineJaundicemedicine.diseaseRetroperitoneal fibrosismedicine.anatomical_structureEsophageal varicesmedicinePortal hypertensionPancreatitismedicine.symptomDifferential diagnosisPancreasbusinessAutoimmune pancreatitisRevista Española de Enfermedades Digestivas
researchProduct

Gastric mucosal resistance to acute injury in experimental portal hypertension

2001

The gastric mucosa of portal hypertensive rats exhibits important microvascular changes and a nitric oxide (NO)-dependent hyperemia. This study analyses whether portal hypertensive mucosa exhibits changes in its ability to withstand aggression. Portal hypertension was induced by partial portal vein ligation (PPVL) or common bile duct ligation (CBDL) and gastric damage was induced by oral administration of ethanol or aspirin. Experiments were performed in conscious or anaesthetized rats and some animals were pre-treated with the NO-synthesis inhibitor L-NAME. Conscious PPVL or CBDL rats showed an increased resistance to the damaging effects of ethanol. Oral administration of aspirin produced…

PharmacologyPentobarbitalAspirinmedicine.medical_specialtyCirrhosisbiologybusiness.industrybiology.organism_classificationmedicine.diseaseNitric oxideNitric oxide synthasechemistry.chemical_compoundEndocrinologymedicine.anatomical_structurechemistryEnosInternal medicinemedicinebiology.proteinGastric mucosaPortal hypertensionbusinessmedicine.drugBritish Journal of Pharmacology
researchProduct